Loraine Klein is a notable inventor based in Streamwood, IL (US). She has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that showcase her innovative approaches to chemical synthesis.

Latest Patents

Her latest patents include the preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide and methods for preparing (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinoline-carboxamide, referred to as 'tic-c'. These patents disclose a process where the initial step involves the phosgenation of a substituted tetrahydroisoquinoline to form an N-carboxy anhydride. Tic-d, the final product, serves as an intermediate in the synthesis of known compounds with pharmaceutical activity. Additionally, she has developed an improved process for the synthesis of asparagine, a non-essential amino acid useful in food and medical applications. This process utilizes mineral acid to create an intermediate beta-methyl aspartate from a reaction mixture of aspartic acid and methanol, allowing for the collection of asparagine without the need for isolating intermediates.

Career Highlights

Throughout her career, Loraine has worked with prominent companies, including Monsanto Company. Her work has significantly impacted the pharmaceutical industry, particularly in the synthesis of important compounds.

Collaborations

Loraine has collaborated with esteemed colleagues such as Robert W. Erickson and David R. Allen, contributing to her success and the advancement of her research.

Conclusion

Loraine Klein's innovative work in pharmaceutical chemistry and her contributions to the synthesis of vital compounds highlight her role as a leading inventor in her field. Her patents reflect her dedication to advancing medical science through chemistry.